Selinexor in Combination with Cladribine, Cytarabine and G-CSF for Relapsed or Refractory AML

被引：0
|
作者：
Uy, Geoffrey L.
Rettig, Michael P.
Fletcher, Theresa
Riedell, Peter A.
Stockerl-Goldstein, Keith E.
Ghobadi, Armin
Jacoby, Meagan
Cashen, Amanda F.
Romee, Rizwan
Pusic, Iskra
Abboud, Camille N.
Schroeder, Mark A.
Vij, Ravi
Westervelt, Peter
DiPersio, John F.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
816
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Use of Clofarabine and Cytarabine Combination (CLARA) As Salvage Therapy for Relapsed and/or Refractory Acute Myeloid Leukemia (AML)
    Leung, Anskar Y. H.
    Tse, Eric
    Liu, Herman S. Y.
    Sim, Joycelyn
    Kho, Bonnie C. S.
    Yip, Sze-Fai
    Lee, Harold K. K.
    Kwong, Yok Lam
    BLOOD, 2012, 120 (21)
  • [42] FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia
    Huhmann, IM
    Watzke, HH
    Geissler, K
    Gisslinger, H
    Jager, U
    Knobl, P
    Pabinger, I
    Korninger, L
    Mannhalter, C
    Mitterbauer, G
    Schwarzinger, I
    Kalhs, P
    Haas, OA
    Lechner, K
    ANNALS OF HEMATOLOGY, 1996, 73 (06) : 265 - 271
  • [43] A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia
    David Martínez-Cuadrón
    Blanca Boluda
    Pilar Martínez
    Juan Bergua
    Rebeca Rodríguez-Veiga
    Jordi Esteve
    Susana Vives
    Josefina Serrano
    Belen Vidriales
    Olga Salamero
    Lourdes Cordón
    Amparo Sempere
    Ana Jiménez-Ubieto
    Julio Prieto-Delgado
    Marina Díaz-Beyá
    Ana Garrido
    Celina Benavente
    José Antonio Pérez-Simón
    Federico Moscardó
    Miguel A. Sanz
    Pau Montesinos
    Annals of Hematology, 2018, 97 : 763 - 772
  • [44] Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy
    Klement, Piroska
    Fiedler, Walter
    Gabdoulline, Razif
    Dallmann, Louisa-Kristin
    Wienecke, Clara Philine
    Schiller, Johannes
    Kandziora, Christian
    Teich, Katrin
    Heida, Bennett
    Buttner, Konstantin
    Brandes, Maximilian
    Funke, Carolin
    Wichmann, Martin
    Othman, Basem
    Chromik, Joerg
    Amberg, Stefanie
    Kebenko, Maxim
    Schlipfenbacher, Vera
    Wilke, Anne Christine
    Modemann, Franziska
    Janning, Melanie
    Serve, Hubert
    Bokemeyer, Carsten
    Theile, Susann
    Deppermann, Ute
    Kranich, Anne L.
    Ganser, Arnold
    Thol, Felicitas
    Heuser, Michael
    ANNALS OF HEMATOLOGY, 2023, 102 (02) : 323 - 328
  • [45] The Application of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Aclarubicin in AML-MRC: A Single Center Case Control Study
    Jiang, Hao
    Liu, Jing
    Liu, Xiaohong
    Jia, Jinsong
    Gong, Lizhong
    Lu, Shengye
    Huang, Xiaojun
    Wang, Jing
    Zhao, Xiaosu
    Lai, Yueyun
    Shi, Hongxia
    Chang, Yingjun
    Ruan, Guorui
    BLOOD, 2021, 138
  • [46] Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy
    Piroska Klement
    Walter Fiedler
    Razif Gabdoulline
    Louisa-Kristin Dallmann
    Clara Philine Wienecke
    Johannes Schiller
    Christian Kandziora
    Katrin Teich
    Bennett Heida
    Konstantin Büttner
    Maximilian Brandes
    Carolin Funke
    Martin Wichmann
    Basem Othman
    Joerg Chromik
    Stefanie Amberg
    Maxim Kebenko
    Vera Schlipfenbacher
    Anne Christine Wilke
    Franziska Modemann
    Melanie Janning
    Hubert Serve
    Carsten Bokemeyer
    Susann Theile
    Ute Deppermann
    Anne L. Kranich
    Arnold Ganser
    Felicitas Thol
    Michael Heuser
    Annals of Hematology, 2023, 102 : 323 - 328
  • [47] Molecular Response Patterns in Relapsed/Refractory AML Patients Treated with Selinexor and Chemotherapy
    Klement, Piroska
    Fiedler, Walter
    Gabdoulline, Razif
    Dallmann, Louisa-Kristin
    Wienecke, Clara
    Schiller, Johannes
    Kandziora, Christian
    Teich, Katrin
    Heida, Bennet
    Brandes, Maximilian
    Funke, Carolin
    Wichmann, Martin
    Othman, Basem
    Chromik, Jorg
    Buettner, Konstantin
    Amberg, Stefanie
    Kebenko, Maxim
    Schlipfenbacher, Vera
    Wilke, Anne C.
    Modemann, Franziska
    Janning, Melanie
    Serve, Hubert
    Bokemeyer, Carsten
    Deppermann, Ute
    Kranich, Anne L.
    Ganser, Arnold
    Thol, Felicitas
    Heuser, Michael
    BLOOD, 2021, 138
  • [48] The combination of cladribine with cytarabine and G-CSF (CLAG) or CLAG with mitoxantrone (CLAG-M) as induction therapy in primary resistant or relapsed acute myeloid leukemia - Polish Adult Leukemia Group (PALG) study.
    Robak, T
    Wrzesien-Kus, A
    Lech-Maranda, E
    Wierzbowska, A
    Sobczak-Pluta, A
    Holowiecki, J
    Kyrcz-Krzemien, S
    Grosicki, S
    Kuliczkowski, K
    Dmoszynska, A
    Kowal, M
    Hellmann, A
    Maj, S
    BLOOD, 2003, 102 (11) : 250B - 250B
  • [49] Allogeneic hematopoietic cell transplantation in aplasia after Cladribine/Cytarabine salvage chemotherapy for refractory or relapsed AML and MDS - a single center experience
    Vydra, Jan
    Markova, Marketa St'astna
    Valkova, Veronika
    Novakova, Ludmila
    Cemusova, Barbora
    Soukup, Petr
    Kolar, Michal
    Vitek, Antonin
    Cetkovsky, Petr
    BONE MARROW TRANSPLANTATION, 2018, 53 : 147 - 148
  • [50] Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia
    Alexander, Thomas B.
    Lacayo, Norman J.
    Choi, John K.
    Ribeiro, Raul C.
    Pui, Ching-Hon
    Rubnitz, Jeffrey E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (34) : 4094 - +
12345